According to research published by the United States Bone and Joint Initiative, musculoskeletal disorders such as arthritis and back pain affect more than 50% of adults in the United States and are ...

Cancer overtook musculoskeletal conditions as the leading condition that is driving up employers’ healthcare costs, a new survey found. The survey conducted by Business Group on Health between May 31 ...

The prevalence and disability-adjusted life years (DALYs) of MSDs in PMW have significantly increased, with OA and lower back pain as leading contributors. High-income regions, such as North America, ...

Orthopedics is entering 2026 amid political, financial and operational challenges. For Kevin Bozic, MD, chair of surgery and perioperative care at Dell Medical School at the University of Texas at ...

Musculoskeletal disorders -- which affect muscles, tendons, ligaments, bones, and joints -- can severely affect individuals' physical and mental health, and they're especially prevalent among aging ...

Whether a worker sits at a desk, provides bedside care in a hospital, drives a truck or works on a production line, he or she is at risk of developing a musculoskeletal disorder (MSD). Musculoskeletal ...

Musculoskeletal disorders--which affect muscles, tendons, ligaments, bones, and joints--can severely affect individuals' physical and mental health, and they're especially prevalent among aging adults ...

A new study highlights the increased health care costs associated with musculoskeletal conditions compared to other diseases. Health care costs were almost 50 percent higher for people with a ...

Musculoskeletal inflammatory conditions in the older patient cover the spectrum of those conditions affecting all age groups to those that are associated with advanced age. Polymyalgia rheumatica and ...

Care Market OverviewThe global digital musculoskeletal (MSK) care market is projected to grow at a significant CAGR of 18–20% over the next five years, driven by multiple transformative forces shaping ...

HOUSTON, Dec. 10, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics” or the “Company”), a clinical-stage biotechnology company with 270+ patents issued and pending with a ...